Medifast Inc banner

Medifast Inc
XMUN:MDF

Watchlist Manager
Medifast Inc Logo
Medifast Inc
XMUN:MDF
Watchlist
Price: 10.84 EUR Market Closed
Market Cap: €902.8m

Medifast Inc
Investor Relations

Medifast sells packaged weight-loss and healthy-eating products, mainly shakes, bars, soups, and other meal replacements. These products are built around its OPTAVIA program, which gives customers a structured plan for losing weight and maintaining habits through portion-controlled eating and coach support. The company’s main customers are adults trying to lose weight or manage their diet in a simple, guided way. Medifast makes money by selling its food products, usually through a network of independent OPTAVIA coaches who help enroll customers, explain the program, and keep them engaged. That makes the business part product company and part service model: the food is the core item being sold, but the coaching and community are a big reason people stick with the program. Medifast sits in the health and wellness aisle, but its model is different from a normal grocery brand because it sells a repeatable program rather than just individual snacks or supplements.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Aug 3, 2026
AI Summary
Q2 2026

Revenue: Second quarter revenue was $76.4 million, down 27.6% year over year, but management said it was in line with guidance and that revenue has stabilized sequentially over recent quarters.

Coach Productivity: Active earning coach productivity improved for the third straight quarter, with revenue per active earning coach up 41.0% year over year and 20% sequentially, a key sign management sees as leading future growth.

Profit Outlook: Medifast reiterated that it expects to return to profitability in the fourth quarter of 2026, helped by the new Catalyst cost-savings program and the launch of Trilivy.

Trilivy Launch: The company is rolling out Trilivy as its new primary consumer brand and said coach and client reception has been very positive, with no major hiccups so far.

Cost Actions: Catalyst is expected to deliver “millions” of dollars in savings, but management said it is still working through the details and will provide more quantification on the Q3 call.

Balance Sheet: Medifast ended the quarter with $169.8 million in cash, cash equivalents, and investments and no debt, which management called a position of strength.

Key Financials
Revenue
$76.4 million
Earnings per share
$0.28 loss per diluted share
Active earning coaches
approximately 11,700
Revenue per active earning coach
$6,529
Gross profit
$53.4 million
Gross margin
69.9%
SG&A expense
$57.7 million
Loss from operations
$4.3 million
Net loss
$3.1 million
Cash, cash equivalents, and investments
$169.8 million
No debt
no debt
Other income
$1.3 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Daniel R. Chard
Executive Chairman & CEO
No Bio Available
Mr. James P. Maloney CPA
Chief Financial Officer
No Bio Available
Mr. Anthony E. Tyree
Chief Business Operations Officer
No Bio Available
Mr. Jason L. Groves Esq.
Executive VP, General Counsel & Corporate Secretary
No Bio Available
Mr. Nicholas M. Johnson
Chief Field Operations Officer
No Bio Available
Mr. Jonathan Barrett MacKenzie
VP of Finance & Chief Accounting Officer
No Bio Available
Mr. Steven Zenker
Vice President of Investor Relations
No Bio Available
Ms. Claudia C. Greninger
Chief Human Resources Officer
No Bio Available

Contacts

Address
MARYLAND
Owings Mills
11445 Cronhill Dr
Contacts
+17327640619.0
www.medifast1.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett